Company Profiles

driven by the PitchBook Platform

Accera

Description

Developer of therapies for treating central nervous systems disorders. The company provides therapies that address metabolic deficiencies leading to Parkinson's and Alzheimer's diseases by offering an alternative energy source for brain cells.

2001

Founded

PRIVATE

Status

11-50

Employees

Series E

Latest Deal Type

$84.1M

Latest Deal Amount

$170M

Total Amount Raised

Description

Developer of therapies for treating central nervous systems disorders. The company provides therapies that address metabolic deficiencies leading to Parkinson's and Alzheimer's diseases by offering an alternative energy source for brain cells.

Website:

www.accerapharma.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Drug Discovery

Primary Office

3005 Center Green Drive Suite 205 Boulder, CO 80301United States +1 (303) 999-3700
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Accera's full profile, request a free trial.

Accera Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Accera Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Accera Investors (4)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Individual InvestorAngel (individual)Minority000 0000000 0000
Inventages Venture CapitalVenture CapitalMinority000 0000000 0000
Nestlé Health ScienceCorporationMinority000 0000000 0000
Posco BioVenturesVenture CapitalMinority000 0000000 0000
Individual Investor Angel (individual)
Inventages Venture Capital Venture Capital
Nestlé Health Science Corporation
Posco BioVentures Venture Capital

Accera Executive Team (8)

NameTitleBoard
Seat
Contact
Info
Charles Stacey MDPresident & Chief Executive Officer
Sabrina GreerDirector, Clinical Operations & Regulatory Affairs
Taryn Boivin Ph.DActing Vice President of CMC
Ernest Wong Ph.DVice President of Corporate Development
Bruce Morimoto Ph.DVice President of Drug Developemnt
Charles Stacey MD President & Chief Executive Officer
Sabrina Greer Director, Clinical Operations & Regulatory Affairs
Taryn Boivin Ph.D Acting Vice President of CMC
Ernest Wong Ph.D Vice President of Corporate Development
Bruce Morimoto Ph.D Vice President of Drug Developemnt

Accera Board Members (6)

NameRepresentingRoleSinceContact
Info
Claude Nash Ph.DSelfChairman000 0000
Grégory BeharNestlé Health ScienceBoard Member000 0000
Gunnar Weikert Ph.DInventages Venture CapitalDirector000 0000
Luis CantarellNestlé Health ScienceDirector000 0000
Sven Thormahlen Ph.DSelfDirector000 0000
Claude Nash Ph.D Chairman Self
Grégory Behar Board Member Nestlé Health Science
Gunnar Weikert Ph.D Director Inventages Venture Capital
Luis Cantarell Director Nestlé Health Science
Sven Thormahlen Ph.D Director Self
Request full access to PitchBook